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Abstract
Summary Compressive fatigue properties of whole vertebrae,
which may be clinically relevant for osteoporotic vertebral
fractures, were determined in untreated, intact rats and
zoledronic-acid-treated, ovariectomized rats. Typical fatigue
behavior was found and was similar to that seen in other
species. Fatigue properties were comparable between both
groups.
Introduction Osteoporosis is often treated with bisphospho-
nates, which reduce fracture risk. Effects of bisphosphonates
on fatigue strength, which may be clinically relevant for
vertebral fractures, are unknown. We determined vertebral,
compressive fatigue properties in normal and zoledronic acid
(ZOL)-treated, OVX rats.
Methods Thirty-five-week old Wistar rats were divided into
SHAM-OVX (n=7) and OVX with ZOL treatment (n=5;
single injection, 20 μg/kg b.w. s.c.). After 16 weeks,
vertebral trabecular microarchitecture and cortical thickness
were determined using micro-CT. Vertebrae were cyclically
compressed in load-control at 2 Hz starting at 0.75%
apparent strain. A line parallel to the apparent strain curve
was drawn at 0.5% higher offset, after which the intersection
was defined as the time to failure and the apparent strain at
failure. Data were compared using Student’s t test.
Results Morphology and fatigue properties were the same
in both groups. Samples failed between 10 min and 15 h.
Force–displacementcurvesdisplayedtypicalfatiguebehavior.
Displacement increased over time due to mostly creep and to
decreasing secant stiffness.
Conclusions We established a technique to determine
compressive fatigue properties in the rat vertebral body.
Our initial results indicate that ZOL-treated OVX rats have




Osteoporosis is a bone disorder that affects millions of
people worldwide. It is characterized by an imbalance in
bone resorption and formation rates [1, 2], resulting in low
bone mass and increased fracture risk. Approximately 50%
of age-related vertebral fractures are believed to be
spontaneous fractures, resulting from daily activities or
from cyclic loading, rather than from trauma [3, 4].
Bisphosphonates are often used to treat osteoporotic
patients. They inhibit bone resorption and thereby slow
down the process of bone loss, maintaining bone mass,
microstructure and strength in relevant anatomical sites like
the femur and vertebra, in animals as well as in humans
[5–7]. Importantly, fracture risk is significantly reduced in
osteoporotic patients treated with bisphosphonates [6, 8–10].
Zoledronicacidisapotent,relativelynewbisphosphonatethat
recentlyhasbeenshowntosignificantlyreducefractureriskin
osteoporotic patients who received once-yearly doses [11].
We have previously shown that zoledronic acid both
inhibited and recovered loss of bone structure and strength
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Bisphosphonates have also been shown to influence the
degree of mineralization of bone tissue due to decreased
bone turnover rates and the subsequent prolongation of
secondary mineralization [14, 15], which may lead to more
brittle mechanical behavior [16–19]. Crystallinity of bone
tissue has been shown to influence monotonic and fatigue
mechanical properties in human cortical bone [20]. Micro-
cracksand diffusedamage are commonlyseeninhuman bone
[21–23] and may act as a stimulus for bone remodeling [24].
Studies in dogs have shown that low resorption rates induced
by bisphosphonates lead to accumulation of microcracks and
diffuse damage [25]. It is unknown whether these increases
in mineralization and microdamage resulting from
bisphosphonates influence the mechanical properties of bone
when cyclically loaded.
Compressive and tensile fatigue behavior has been well
documented for cortical bone from humans as well as
animals [26–29]. More recently, the fatigue behavior of
trabecular bone in animals and humans has been found to
exhibit similar characteristics as cortical bone [30–33].
Although these studies have provided fundamental infor-
mation regarding bone fatigue behavior, the integral
function of cortical and trabecular bone, i.e., the way they
act together, which plays an important role in the vertebra,
has not yet been determined. Moreover, drug efficacy studies
in rats generally focus on changes in bone mass, structure,
and static mechanical strength, whereas fatigue behavior,
which may play an important role in vertebral fractures, may
respond differently to pharmacologic intervention than other
statically determined mechanical parameters.
Our primary aim was to develop an experimental approach
to determine compressive fatigue mechanical properties in
whole rat vertebra. We then used this method to compare
fatigue properties in ovariectomized rats treated with zole-
dronic acid to SHAM, ovariectomized controls, which
exhibited similar structural and static, compressive properties.
Materials and methods
Seventeen female, 35-week-old, Wistar rats were used from
a previous study described elsewhere [12]. At week 0, eight
rats were ovariectomized (OVX-ZOL), and nine rats were
SHAM-ovariectomized (SHAM-OVX). Zoledronic acid
was kindly provided as the disodium salt hydrate by
Novartis Pharma AG (Basel, Switzerland) and was dissolved
in a saline vehicle prior to injection. It was administered at a
single dose of 20 μg/kg body weight s.c. at the time of OVX
to all rats of the OVX-ZOL group. The dose was chosen
based on a dose–response study in rats, in which 20 μg/kg
body weight was found to be most effective [34]. Rats were
humanely sacrificed 16 weeks later, and whole L4 vertebrae
were dissected, soaked in 0.9% saline solution gauze, and
frozen at −20°C. This study was approved by the Animals
Ethics Committee of the University of Maastricht, the
Netherlands.
Micro-CT scanning
Vertebrae were thawed to room temperature and scanned
with a desktop micro-CT system (microCT40, Scanco
Medical AG, Bruettisellen, Switzerland) at an isotropic
resolution of 16 μm (55 kV, 145 μA, 500 projections per
180°, 200 ms integration time). After scanning, samples
were frozen again until mechanical testing. Images were
Gaussianfiltered(sigma=0.8,support=1voxel)andbinarized
to separate bone from background using a global thresholding
procedure [35].
From the CT scans, the trabecular region was manually
selected starting ten slices below the cranial growth plate
and ending ten slices above the caudal growth plate,
resulting in a trabecular region of approximately 5 mm in
axial direction. From this region, six bone structural
parameters (bone volume fraction (BV/TV), connectivity
density (Conn.D), structure model index (SMI), trabecular
number (Tb.N), trabecular thickness (Tb.Th), and separation
(Tb.Sp)) were automatically determined. Cortical bone was
semi-automatically delineated from the CTscans by drawing
contour lines, using the same set of slices as used for
trabecular bone measurements.
Specimen preparation
To achieve plano-parallel ends, vertebrae were fixed in a
custom-made jig. A double-blade, wafering, low-speed
diamond saw (Isomet, Buehler, Lake Bluff, IL, USA) was
used under constant saline irrigation to remove cranial and
caudal ends including the growth plate. After sawing, the
exact vertebral height was measured using a caliper and
found to be 4.06±0.09 mm (mean ± SD). An example of a
processed vertebra can be seen in Fig. 1. A single-blade,
wafering, low-speed diamond saw was used under constant
saline irrigation to remove all posterior pedicles and
processes. Anterior elements were clipped off using a
rounger, resulting in a separated vertebral body. CT scans
taken for pilot samples had shown no splintering resulted
from sawing and clipping. Vertebrae were kept frozen in a
0.9% saline solution until fatigue testing.
Fatigue compression tests
Vertebrae were thawed to room temperature prior to
mechanical testing. In total, all samples were frozen and
thawed for three cycles. Previously, five cycles of freezing
1378 Osteoporos Int (2009) 20:1377–1384and thawing has been found not to affect mechanical
properties determined in a static, compression [36], and
indentation test [37]. Therefore, we assumed that fatigue
properties determined in our study were not affected by the
freezing and thawing. L4-vertebral bodies were used for
fatigue compression tests, which were conducted in load-
control at 25°C. A custom-made, steel lower plate was
designed in the form of a cup (Fig. 1). The vertebral body
was placed with the cranial end facing upward in the lower
cup of the testing machine (Instron 8874, Instron Corp.
Canton, MA, USA). The top platen, smaller in diameter than
the cup, was lowered onto the vertebra to a compressive
preload of 5 N, at which point the displacement was set at
zero. Displacement was measured from the actuator dis-
placement transducer of the testing machine. A 0.9% saline
solution containing protease inhibitors was added to the cup
to prevent the vertebra from dehydrating and to inhibit
microorganism growth. Since bone is known to fail at a
certain strain rather than at a certain load or stress [38, 39]
and since our aim was to compare the fatigue properties at
the tissue rather than structural level between the two
groups, all tests were started at the same apparent strain. In
a pilot study, the relation between initial apparent strain and
number of cycles to failure was studied. Thirteen samples
were tested between 0.6% and 0.94% initial apparent strain.
A significant correlation (r
2=0.48, p=0.009) was found
between the log of strain and log of number of cycles,
which corresponds to typical fatigue behavior [27, 30–33].
It was found that 0.75% initial apparent strain resulted in a
reasonable number of cycles to failure (average number of
cycles ∼40,000), and therefore, this value was used in all
tests. Since the stiffness varied per sample and the test was
run in load-control, the load needed to reach the initial
apparent strain criterion varied as well. Therefore, prior to
testing, each sample was cyclically loaded for about 400
cycles with increasing load until the load was reached at
which the desired apparent strain was met. The maximum
load ranged from 63 to 97 N.
During the test, load cycled between 5 N and the
determined maximum load in a sinusoidal shape at a
frequency of 2 Hz. Tests were ended after the sample
failed, which was characterized firstly by an increasing
displacement range per cycle, increased hysteresis, and
increased total apparent strain. Then, the sample could not
bear the loads anymore and was crushed. A full load–
displacement cycle could not be reached anymore, after
which the test was stopped. Tests were stopped after
120,000 cycles if failure had not occurred. Every fourth
cycle, force and displacement were acquired during one
cycle at a sampling frequency of 100 Hz.
For each sample, creep characteristics exhibited three
classical phases: an initial phase of high creep rate, a phase
of a lower creep rate, and a phase in which creep rate was
high again, finally resulting in failure (Figs. 2 and 3)[ 33,
40]. From each apparent strain versus time curve, the
steady-state creep rate of the secondary phase was
determined by fitting a linear line through the central part
of the curve. According to the method of Bowman et al.
[33], a line parallel to this line was drawn at 0.5% higher
offset. The intersection of this line with the apparent strain
curve was defined as the time to failure and the apparent
strain at failure. Young’s modulus could not be properly
calculated, as the effective area in a vertebra that contains
trabecular and cortical bone varies going from cranial to
caudal ends. Therefore, secant stiffness was calculated for
each recorded cycle by dividing the load range by the
displacement range of that cycle. Initial secant stiffness was
determined at the start of the experiment, and final secant
stiffness was determined at the time of failure. For each
sample, time to failure, apparent strain at failure, steady-
state creep rate, initial stiffness, and percent loss of stiffness
at failure were calculated.
Data analysis
Pearson correlation coefficients were used to determine the
relation between trabecular bone microarchitecture, cortical
thickness, and compressive fatigue properties. For this, all
structural properties were correlated with fatigue properties
as well as with log-transformed values of the fatigue
properties. Also, all structural and fatigue parameters were
Fig. 1 Schematic of fatigue loading test. The lower platen, designed
as a cup, contained the vertebra. The top platen, smaller in diameter
than the cup, was lowered onto the vertebra to a compressive preload
of 5 N, at which point the displacement was set at zero. A 0.9% saline
solution containing protease inhibitors was added to the cup to prevent
the vertebra from dehydrating and to inhibit microorganism growth
Osteoporos Int (2009) 20:1377–1384 1379compared between the two groups using a Student’s t test. p
values below 0.05 were considered significant.
Results
During fatigue testing, 12 samples failed between 10 min
and 14.7 h (1,200 and 106,000 cycles), and five samples
did not fail within the studied period of time. The latter
samples showed a decreasing, rather than an increasing,
apparent strain range per cycle during the test, accompanied
by an increasing secant stiffness, suggesting that artifacts
were present in these tests [41]. These samples were
subsequently removed from all analyses in the study,
resulting in seven samples in the SHAM-OVX and five in
the OVX-ZOL group.
Trabecular and cortical microarchitecture
No significant differences were found in trabecular bone
microarchitecture and cortical thickness between the
SHAM-OVX- and the OVX-ZOL-treated group except for
Tb.Th, which was significantly higher in the ZOL-treated
group (Table 1). These results indicate that ZOL treatment
inhibited bone loss and trabecular deterioration that has
previously been shown to occur after ovariectomy [13].
Fatigue compression tests
For all failed samples, force–displacement cycles displayed
typical fatigue behavior characterized by decreasing secant
stiffness, increasing hysteresis, and increasing nonlinearity
(Fig. 2). Displacement increased over time due to mostly
creep and to a lower extent, decreasing secant stiffness. For
each sample, the steady-state creep rate was determined
from the apparent strain versus time curve, as well as the
time to failure and apparent strain at failure (Fig. 3).
Time to failure, apparent strain at failure, steady-state creep
rate,initialstiffness,andpercentlossofstiffnessatfailurewere
not significantly different between the two groups (Table 2).
Steady-state creep rate and log of the time to failure have
shown to be inversely linearly correlated in compressive
fatigue studies on bovine trabecular bone [32, 33]. Here, we
also found a strong inverse correlation between log of the
steady-state creep rate and log of the time to failure of all
samples taken together (r
2=0.86, p<0.001, Fig. 4). The
relationship between steady-state creep rate and time to
failure was similar between SHAM-OVX and OVX-ZOL.
Fig. 3 Typical sample for which creep characteristics exhibit three
typical phases of fatigue: an initial phase of high creep rate, a phase of
a steady-state lower creep rate, and a phase in which creep rate is high
again, finally resulting in failure [33, 40]. From each apparent strain
against time curve, the creep rate of the secondary phase is determined
by fitting a linear line. According to the method of Bowman et al.
[33], a line parallel to this line is drawn at 0.5% higher offset. The
intersection of this line with the apparent strain curve is defined as the
time to failure and the strain at failure
Fig. 2 T h r e er e p r e s e n t a t i v ef o r c e –
displacement cycles throughout the
testing period: 20, 55, and 10,620
cycles for a typical sample. Force–
displacement cycles display typical
fatigue behavior characterized by
decreasing secant stiffness, increas-
ing hysteresis, and increasing non-
linearity. Displacement increases
over time due to mostly creep and
to a lower extent, a decreasing
secant stiffness
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BV/TV, Conn.D, Tb.N, and Tb.Sp each correlated with
apparent strain at failure as well as with log of the apparent
strain at failure (0.31<r
2<0.50, p<0.05). All other correla-
tions between morphologic parameters and fatigue properties
were not significant (Fig. 5).
Discussion
In this study, we developed a method for assessing the fatigue
propertiesofwholeratvertebrae.Typicalfatiguebehaviorwas
seen in SHAM-ovariectomized as well as in ZOL-treated,
ovariectomized rats. Fatigue properties, trabecular micro-
architecture, and cortical thickness were similar in both
groups. Previously, we showed that static compressive
behavior was also similar in L3 vertebrae of the same groups
of rats [13]. Altogether, this suggests that ZOL treatment of
ovariectomized rats results in the same vertebral bone mass
and structure as SHAM, ovariectomized rats, as well as the
same vertebral static and fatigue properties.
For all vertebrae, force–displacement curves displayed
typical fatigue behavior characterized by decreasing secant
stiffness, increasing hysteresis, and increasing nonlinearity.
This agrees with compressive, fatigue behavior previously
reported for cortical and trabecular bone specimens [27,
31–33]. Also, the strong linear correlation between the log
steady-state creep rate and the log time to failure agrees
with the literature [32, 33], which indicates the validity of
the test. This also indicates that the integral fatigue behavior
of cortical and trabecular bone in rats is similar to the two
bone compartments assessed separately. We found an
average apparent strain at failure of about 4% for both
groups, which is just slightly higher than the 3.4% and 2.8%
reported for, respectively, human and bovine trabecular bone
[31, 33].
Samples that did not fail during the test were removed
from further analysis and showed a decreasing rather than
an increasing apparent strain range per cycle during the test
accompanied by an increasing secant stiffness. This
behavior suggests that artifacts were present in these tests
[41, 42], possibly due to vertebral ends that were not
perfectly parallel. In this case, when the force range,
leading to 0.75% apparent strain, was determined at the
start of the test, the actual area bearing the load would be
smaller than the total bone area. During the test, the area
bearing the load would then be compressed, resulting in the
same load being born by the area of the whole vertebra and
thus in lower strains. Improving the sawing procedure and
specimen fixation in the loading device could possibly
reduce the rate of exclusion of samples.
The fatigue behavior in these whole vertebrae was
comparable to the fatigue behavior found in studies on
cortical and trabecular bone, though no fatigue data on rat
bone are available. Although not determined in our study, it
would be interesting to study whether failure starts in the
cortical or trabecular bone.
Most of the fatigue properties were unrelated to cortical
or trabecular bone morphology, with the exception of weak
relationships between trabecular bone morphology and
apparent strain at failure. Vertebral morphology and micro-
architecture were similar in both groups, and any intrinsic
variance in bone mass and stiffness was accounted for in
the fatigue test by starting all tests at the same apparent
strain level. One might therefore expect that trabecular
microarchitecture would not be well correlated with fatigue
properties in this test protocol. However, it is possible that
despite our normalized test, some types of structure are
more favorable over time in a fatigue test than others,
Table 1 Cortical thickness, trabecular bone volume, and trabecular microarchitecture as determined by micro-CT in L4 vertebrae (mean ± SD)










SHAM-OVX (n=7) 0.288 (±0.034) 60.5 (±25.0) 0.554 (±0.319) 3.27 (±0.583) 89.4 (±5.3) 290 (±46) 174 (±12)
OVX-ZOL (n=5) 0.285 (±0.043) 43.8 (±11.5) 0.425 (±0.461) 2.91 (±0.500) 95.8 (±1.5) 335 (±70) 183 (±12)
Parameters in bold are significantly different between groups (p<0.05 by unpaired t test)











SHAM-OVX (n=7) 5.42 (±4.67) 4.19 (±1.52) 0.80 (±1.25) 2,193 (±285) 20.11 (±6.68)
OVX-ZOL (n=5) 5.51 (±5.80) 4.30 (±1.50) 0.50 (±0.37) 2,396 (±191) 16.96 (±9.59)
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parameter and a fatigue property. Additional studies need to
be conducted to further delineate the possible relationship
between bone microarchitecture and fatigue behavior.
Notably, in human trabecular bone, bone volume fraction
is weakly correlated with strain at failure, which agrees
with our findings [30].
Rather than applying the same load, which will result in
low bone mass samples failing earlier than high bone mass
samples, we applied the same apparent strain in each test.
By developing this normalized fatigue test, we aimed at
determining changes in fatigue properties due to differences
at the tissue rather than the structural level. The fact that no
difference in fatigue behavior was found between both
groups indicates that either no changes occurred in the bone
tissue fatigue properties or that we were unable to detect
them. Increased mineralization that may have taken place in
the ZOL group due to lower turnover rate apparently did
not lead to detectable changes in fatigue properties of the
bone tissue. It may be, however, that a longer treatment
period would have led to noticeable changes. Also, no
untreated OVX group was included in this study, and
therefore, the effects of OVX versus those associated with
ZOL treatment cannot be distinguished. Theoretically, it
could be that OVX would lead to altered fatigue properties,
which could have then been reversed by ZOL resulting in
no differences between SHAM-OVX- and ZOL-treated
OVX rats. This will need to be tested by additional studies.
In our study, several samples did not fail during the test,
which reduced the sample size. Also, between-subject
variation was found to be high, which, combined with the
small sample size, reduced the power to detect differences
between the groups. A power analysis revealed that a
scientifically relevant difference of 30% between the two
groups in apparent strain at failure would have been
detectable if the sample size would have been 22.
Therefore, large sample sizes would have been needed to
detect any scientifically relevant differences, which were
not noted in this study. Also, after starting the test, all
samples needed to “settle in”. Thus, strains sometimes
decreased or increased slightly directly after starting the
test, and this may have affected the time to failure.
However, this phenomenon occurred in both groups and,
therefore, would not be expected to contribute to group-
related differences. The sufficient quality of the fatigue test,
however, was reflected in the fact that typical fatigue
behavior was seen in terms of force–displacement curves
and a strong correlation between steady-state creep rate and
log of the time to failure. No observation of substantial
differences between groups was found, and this study
presents therefore the first indication that ZOL-treated,
ovariectomized rats have similar fatigue properties as
control rats. More studies are needed to further elucidate
the effects of bisphosphonates on fatigue properties. The
gained insight in testing limitations will allow for future
study designs to be optimized.
In this study, we developed a method to determine
compressive fatigue mechanical behavior of whole vertebrae
in rats. Fatigue properties of whole rat vertebra exhibited
similarcharacteristics asisolatedcortical andtrabecularbone
specimens. Vertebral morphology, as well as fatigue proper-
Fig. 5 A nonsignificant and a
significant correlation between,
respectively, cortical thickness
and apparent strain at failure and
BV/TV and apparent strain at
failure
Fig. 4 Steady-state creep rate plotted against time to failure for all
samples on a log–log scale. A significant inverse linear correlation
was found between log of the time to failure and log of the steady-
state creep rate (r
2=0.84, p<0.001)
1382 Osteoporos Int (2009) 20:1377–1384ties of ZOL-treated ovariectomized rats, were similar to
SHAM-OVX rats. These findings indicate that ZOL treat-
ment does not have a pronounced negative influence on
cyclic mechanical properties, as might be expected if ZOL-
treated bone tissue were more brittle or contained excessive
microdamage. The development of this methodology will
allow further investigation of the effects of osteoporosis
treatments on vertebral compressive fatigue behavior.
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